Low-dose Paclitaxel-coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: 1-year Results of the ILLUMENATE European Randomized Clinical Trial

Superiority with a low-dose paclitaxel-coated balloon (DCB) when used for femoropopliteal interventions was demonstrated over standard balloon percutaneous transluminal angioplasty (PTA) by both safety and effectiveness end points.

Source: Journal of Vascular Surgery - July 20, 2017 Category: Surgery Authors: H. Schroeder, M. Werner, D.R. Meyer, P. Reimer, K. Kruger, M.R. Jaff, ILLUMENATE EU RCT Investigators Tags: Abstract Source Type: research